Cargando…
‘Strategic’ development of precision cancer medicine in the United States
The availability of advanced omics technologies has largely driven development of precision cancer medicine in the United States, but integration in routine cancer care has been challenging. Here, we consider some parameters that would enable a more coordinated, integrated, efficient, and equitable...
Autor principal: | Schilsky, Richard L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8253098/ https://www.ncbi.nlm.nih.gov/pubmed/34053185 http://dx.doi.org/10.1002/1878-0261.13023 |
Ejemplares similares
-
Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development
por: Santus, Enrico, et al.
Publicado: (2021) -
Precision regenerative medicine
por: Lightner, Amy L., et al.
Publicado: (2021) -
Personalized medicine in Parkinson's disease: Time to be precise
por: Titova, Nataliya, et al.
Publicado: (2017) -
Precision medicine in kidney disease: the patient’s view
por: Brown, Keith D., et al.
Publicado: (2020) -
Precision Public Health and Structural Racism in the United States: Promoting Health Equity in the COVID-19 Pandemic Response
por: Geneviève, Lester Darryl, et al.
Publicado: (2022)